Screening for noncardia gastric cancer may be costeffective

Screening for noncardia gastric cancer may be costeffective PharmacoEconomics & Outcomes News 804, p30 - 2 Jun 2018 Screening for noncardia gastric cancer may be cost effective Endoscopic screening for noncardia gastric adenocarcinoma (NCGA) appears to be cost effective for ethnic groups in the US, according to findings of a study published in Gastroenterology. A Markov model was used to compare the cost effectiveness of a no screening (current standard) for noncardia gastric cancer, or one of two endoscopic screening stategies at the time of screening colonoscopy in 50-year-old non-Hispanic Whites, non-Hispanic Blacks, Hispanics or Asians: upper endoscopy (esophagogastroduodenoscopy [EGD]) with biopsies and continued surveillance in patients with intestinal metaplasia or severe pathology; or EGD with biopsies every two years. Cost effectiveness was assessed from a US healthcare perspective over a 30-year time horizon. The estimated incremental cost effectiveness ratio of EGD screening with surveillance if indicated, compared with no screening or biennial screening, was $122 428 per QALY gained in non-Hispanic Whites, $80 278 per QALY in non-Hispanic Blacks, $76 070 per QALY gained in Hispanics and $71 451 per QALY gained in Asians. EGD screening with surveillance if indicated was therefore cost effective at a willingness-to-pay threshold of $100 000 per QALY gained in non-Hispanic Blacks, Hispanics and Asians in the US, but not in non-Hispanic Whites. No screening was the most cost effective strategy in non-Hispanic Whites. "We found that targeted endoscopic screening (and surveillance if indicated) for NCGA among high-risk groups according to race and ethnicity might be a cost effective intervention in the US despite an overall low background prevalence of disease," said the authors. * 2015 US dollars Saumoy M, et al. Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity. Gastroenterology : 17 May 2018. Available from: URL: https:/ /doi.org/10.1053/j.gastro.2018.05.026 803323155 1173-5503/18/0804-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved PharmacoEconomics & Outcomes News 2 Jun 2018 No. 804 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png PharmacoEconomics & Outcomes News Springer Journals

Screening for noncardia gastric cancer may be costeffective

Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/screening-for-noncardia-gastric-cancer-may-be-costeffective-yxgk0zukv5
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Pharmacoeconomics and Health Outcomes; Quality of Life Research; Health Economics; Public Health
ISSN
1173-5503
eISSN
1179-2043
D.O.I.
10.1007/s40274-018-4994-z
Publisher site
See Article on Publisher Site

Abstract

PharmacoEconomics & Outcomes News 804, p30 - 2 Jun 2018 Screening for noncardia gastric cancer may be cost effective Endoscopic screening for noncardia gastric adenocarcinoma (NCGA) appears to be cost effective for ethnic groups in the US, according to findings of a study published in Gastroenterology. A Markov model was used to compare the cost effectiveness of a no screening (current standard) for noncardia gastric cancer, or one of two endoscopic screening stategies at the time of screening colonoscopy in 50-year-old non-Hispanic Whites, non-Hispanic Blacks, Hispanics or Asians: upper endoscopy (esophagogastroduodenoscopy [EGD]) with biopsies and continued surveillance in patients with intestinal metaplasia or severe pathology; or EGD with biopsies every two years. Cost effectiveness was assessed from a US healthcare perspective over a 30-year time horizon. The estimated incremental cost effectiveness ratio of EGD screening with surveillance if indicated, compared with no screening or biennial screening, was $122 428 per QALY gained in non-Hispanic Whites, $80 278 per QALY in non-Hispanic Blacks, $76 070 per QALY gained in Hispanics and $71 451 per QALY gained in Asians. EGD screening with surveillance if indicated was therefore cost effective at a willingness-to-pay threshold of $100 000 per QALY gained in non-Hispanic Blacks, Hispanics and Asians in the US, but not in non-Hispanic Whites. No screening was the most cost effective strategy in non-Hispanic Whites. "We found that targeted endoscopic screening (and surveillance if indicated) for NCGA among high-risk groups according to race and ethnicity might be a cost effective intervention in the US despite an overall low background prevalence of disease," said the authors. * 2015 US dollars Saumoy M, et al. Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity. Gastroenterology : 17 May 2018. Available from: URL: https:/ /doi.org/10.1053/j.gastro.2018.05.026 803323155 1173-5503/18/0804-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved PharmacoEconomics & Outcomes News 2 Jun 2018 No. 804

Journal

PharmacoEconomics & Outcomes NewsSpringer Journals

Published: Jun 2, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off